Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
20.38
+0.19 (0.94%)
Nov 19, 2025, 12:04 PM EST - Market open
Arcus Biosciences Market Cap
Arcus Biosciences has a market cap or net worth of $2.2 billion as of November 19, 2025. Its market cap has increased by 55.28% in one year.
Market Cap
2.20B
Enterprise Value
1.51B
1-Year Change
55.28%
Ranking
Category
Stock Price
$20.38
Market Cap Chart
Since March 15, 2018, Arcus Biosciences's market cap has increased from $704.52M to $2.20B, an increase of 212.34%. That is a compound annual growth rate of 15.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2025 | 2.18B | 59.99% |
| Dec 31, 2024 | 1.36B | -4.70% |
| Dec 29, 2023 | 1.43B | -4.52% |
| Dec 30, 2022 | 1.50B | -47.33% |
| Dec 31, 2021 | 2.84B | 68.68% |
| Dec 31, 2020 | 1.69B | 263.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 914.81B |
| Johnson & Johnson | 480.85B |
| AbbVie | 413.57B |
| UnitedHealth Group | 290.34B |
| AstraZeneca | 277.65B |
| Novartis AG | 255.14B |
| Merck & Co. | 230.48B |
| Abbott Laboratories | 226.11B |